Difference between revisions of "Part:BBa K4789002:Design"

 
 
(2 intermediate revisions by the same user not shown)
Line 4: Line 4:
  
 
<partinfo>BBa_K4789002 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K4789002 SequenceAndFeatures</partinfo>
−
 
  
 
===Design Notes===
 
===Design Notes===
−
1
+
pre-miR-22 was designed according to its full sequence.
−
 
+
−
 
+
  
 
===Source===
 
===Source===
Line 16: Line 13:
  
 
===References===
 
===References===
 +
[1] Nejati Kazem,Alivand MohammadReza,Arabzadeh AmirAhmad,MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.[J] .Pathol Res Pract, 2021, 223: 153452.
 +
 +
[2]Konishi Hiromi,Hayashi Masami,Taniguchi Kohei et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.[J] .Cancer Biol Ther, 2020, 21: 1128-1135.
 +
 +
[3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520.

Latest revision as of 07:57, 6 October 2023


pre-miR-22


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Design Notes

pre-miR-22 was designed according to its full sequence.

Source

Pre-mir-22 were synthesized by Nanjing Genscript Biotechnology corporation.

References

[1] Nejati Kazem,Alivand MohammadReza,Arabzadeh AmirAhmad,MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.[J] .Pathol Res Pract, 2021, 223: 153452.

[2]Konishi Hiromi,Hayashi Masami,Taniguchi Kohei et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.[J] .Cancer Biol Ther, 2020, 21: 1128-1135.

[3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520.